Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue.
about
Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumorsInhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsutaDeciphering the role of nuclear and cytoplasmic IKKα in skin cancerEnhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes.NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3.Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype.NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiationMucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-κB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissue.Bardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice.Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic miceDiallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3β.Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patientsRole of IKKα in skin squamous cell carcinomas.NF-κB in colorectal cancer.The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance.Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity.A systematic survey of the response of a model NF-κB signalling pathway to TNFα stimulation.The ANK repeats of Notch-4/Int3 activate NF-κB canonical pathway in the absence of Rbpj and causes mammary tumorigenesis.Effects of dark chocolate on azoxymethane-induced colonic aberrant crypt foci.Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.The Adverse Effects of Se Toxicity on Inflammatory and Immune Responses in Chicken Spleens.Molecular Regulation of Sprouting Angiogenesis.Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer.The Biological Activities of Oleocanthal from a Molecular Perspective.Toxicological Effect of Manganese on NF-κB/iNOS-COX-2 Signaling Pathway in Chicken Testes.Prognostic significance of kappaB-Ras1 expression in gliomas.Increased Nuclear Factor-κB/RelA Expression Levels in Human Colorectal Carcinoma in North Indian PatientsMechanistic evidence that benzo[a]pyrene promotes an inflammatory microenvironment that drives the metastatic potential of human mammary cellsImpact of cyclooxygenase-2 over-expression on the prognosis of colorectal cancer patients. An experience from Western Saudi Arabia
P2860
Q27332624-840A1250-43CA-4C7F-89A6-758D1A6FB2B4Q28481494-E7063B04-259F-41BC-A222-3A030F1A7AAFQ28828173-FB0AF467-C11F-46F2-BB31-B4F4BBA82DE2Q30540016-BB26DCF4-396C-4F8D-9D1D-2715ADB1518CQ34324711-8C0A7BD3-AAA0-4CF4-9C6E-B3E9473F5E8AQ34672741-5BF9E26B-7A0D-4E6E-ADD1-0FDBBF55BCAEQ34687041-1FF335D9-B40C-45F0-9500-A8D6277E1405Q34810309-0E9064E7-CE4E-4080-9004-98E25BF5F675Q35684534-094112E4-2DE6-4294-8083-92C80B9ECBCBQ35770197-48EAD83E-98A2-481B-8CC5-C29E1F14D88EQ35846935-396F4DBF-1E3E-4B7C-9893-C73FA938848FQ36670803-33050E00-93A9-4B0A-ABC3-384C988F0143Q36756653-55460593-99C8-43C2-AC0D-D3C008228930Q36791018-185416BF-CE15-47B1-9A1B-49DC3D6342ABQ37059897-2F9BB7D5-A942-48CC-BD1E-E5627E6F8508Q37211803-D5BE0287-CB27-4E1E-A1DB-6F98634D4C28Q37822741-28C699AA-E937-4AF2-8A99-3963C77A0416Q38103447-E5AA27C6-D31F-4273-ADF0-CED165359D08Q39377881-29B8BA7E-D002-4A35-8386-8C19D91AA3E5Q39541011-230D3375-B1EC-46B4-8F6D-A81A705343E9Q42157491-4EEB5FA7-73B0-4496-ACB3-DA743333DDCCQ42652857-76227AC2-AC44-4CD0-AE0B-1440F67884B5Q43897810-6732929F-F1BF-4764-BF09-4203813FB34BQ44707208-BFE0552F-5C61-4F2E-8E76-34A17BF1EF2AQ47199495-376AA9A6-8031-44B7-BE28-27A4A741F58BQ50423780-6A2DC281-9101-4BF7-AB07-C4F3ECDC832BQ50893711-A7F5B999-9D59-45AE-9A9F-EE55CEBD4A86Q53397945-CA985F9C-D861-4FBF-95E7-374E3E0DF261Q53530870-9E4F009C-96A3-4FDC-B659-365F95087F6BQ55463429-95AEB08D-8658-43AB-A557-73ACD7A0CDEAQ57486990-895355E1-0AAD-40FB-9DD6-6683B2871D9AQ58704736-7C44B119-AA10-46BA-8E85-E612CC69DA8FQ58804016-588C9FFC-5876-4C00-B0B9-1720CA7910B1
P2860
Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@en
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@en-gb
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@nl
type
label
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@en
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@en-gb
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@nl
prefLabel
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@en
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@en-gb
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@nl
P2093
P2860
P356
P1476
Expression of COX-2, NF-kappaB ...... ormal human colorectal tissue.
@en
P2093
M P Charalambous
N J Gooderham
T Lightfoot
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605120
P407
P577
2009-06-09T00:00:00Z